Actively Recruiting
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
Led by Tanta University · Updated on 2020-01-03
60
Participants Needed
1
Research Sites
582 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome
CONDITIONS
Official Title
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Male and female participants with a negative pregnancy test and effective contraception
- Diagnosis of IBS according to Rome criteria IV
- Average numeric pain rating scale of 4 or higher during the previous seven days before the inclusion visit
- Stable IBS treatment for at least 1 month
You will not qualify if you...
- Breastfeeding
- Diabetes
- Significant liver function abnormalities (transaminases > 3 times normal, cholestasis) or moderate kidney disease (MDRD < 60 ml/min)
- Addiction to alcohol or drugs
- Current use of antiepileptic drugs for epilepsy or chronic pain
- Chronic pain more severe than IBS-related pain
- Known allergy to succinimides (ethosuximide, methsuximide, phensuximide) or pentoxifylline
- History or current severe depression requiring hospitalization or long-term antidepressant treatment
- Psychotic disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Tanta, Egypt
Actively Recruiting
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here